Hyaluronic acid/lactose-modified chitosan electrospun wound dressings - Crosslinking and stability criticalities.

Carbonyldiimidazole Crosslinking Electrospun wound dressings Hyaluronic acid Lactose-modified chitosan Polysaccharides

Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Jul 2022
Historique:
received: 28 12 2021
revised: 09 03 2022
accepted: 16 03 2022
entrez: 22 4 2022
pubmed: 23 4 2022
medline: 26 4 2022
Statut: ppublish

Résumé

Polysaccharide electrospun wound dressings should be an effective strategy in the field of wound care, as they combine an extracellular matrix-like structure with excellent biomimicry. However, their high hydrophilicity and large surface area cause a rapid dissolution in aqueous environments, compromising their clinical employment. In the present paper, electrospun membranes prepared using hyaluronic acid, a bioactive lactose-modified chitosan (CTL), and polyethylene oxide have been crosslinked using glutaraldehyde, genipin, EDC/NHS or thermal treatments, obtaining very poor results in terms of membrane stability. Therefore, carbonyldiimidazole (CDI) and methacrylic anhydride were investigated in an innovative way, where CDI proved to be the best compromise between nanofiber water resistance, architecture maintenance and degradability. Indeed, the swelling and degradation behavior as well as the water vapor permeability of these matrices were tested, revealing the effectiveness of the electrospun products in absorbing large amount of liquid while maintaining the balance between water retention and gas permeability.

Identifiants

pubmed: 35450637
pii: S0144-8617(22)00279-X
doi: 10.1016/j.carbpol.2022.119375
pii:
doi:

Substances chimiques

Hyaluronic Acid 9004-61-9
Chitosan 9012-76-4
Lactose J2B2A4N98G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119375

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Martina Gruppuso (M)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Electronic address: martina.gruppuso@phd.units.it.

Francesco Iorio (F)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Electronic address: francesco.iorio@fau.de.

Gianluca Turco (G)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Electronic address: gturco@units.it.

Eleonora Marsich (E)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Via Licio Giorgieri 5, 34129, Trieste, Italy. Electronic address: emarsich@units.it.

Davide Porrelli (D)

Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, 34129, Trieste, Italy. Electronic address: dporrelli@units.it.

Articles similaires

Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Animals Drug Resistance, Multiple, Bacterial Mice Microbial Sensitivity Tests Female
Fusarium Pigments, Biological Gamma Rays Chitosan Culture Media

Classifications MeSH